Skip to content

Clinical trials

Lymphoma, B-Cell trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Country / region: Taiwan Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20132
20161
20171
20192
20203
20217
20222
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting11
Completed5
Recruiting5
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
AstraZeneca4
Celgene2
National Taiwan University Hospital2
Regeneron Pharmaceuticals2
Acepodia Biotech, Inc.1
Acerta Pharma BV1
Epizyme, Inc.1
Genmab1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell25
Lymphoma, Non-Hodgkin14
Lymphoma, Large B-Cell, Diffuse7
Hematologic Diseases5
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Follicular5
Lymphoma4
Leukemia, B-Cell3
Lymphoma, Mantle-Cell3
Recurrence3

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.